3 enrolling by invitation. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Enrolling by invitation 3 |
| Phase 3 | 1 | Enrolling by invitation 1 |
Follow Perceptual Disorders: new trials by email Literature Review of Perceptual Disorders trials Research Report on Perceptual Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis ML-007C-MA - Psychosis Associated With Alzheimer's Disease | Phase 2 | Enrolling by invitation | MapLight Therapeutics | 210 | 2026-03-25 | 2026-08-07 |
| Low Dose Dexmedetomidine as a Postoperative Pain Adjunct Dexmedetomidine, Normal Saline - Spinal Fusion, Adolescent Idiopathic Scoliosis | Phase 2 | Enrolling by invitation | Nichole Doyle | 46 | 2024-07-01 | 2026-10-05 |
| Dexmedetomidine in Postoperative Analgesia Dexmedetomidine - Pain Management | Phase 2 / Phase 3 | Enrolling by invitation | New Valley University | 100 | 2023-08-01 | 2026-05-07 |
Agnosia (2) · Alzheimer Disease (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Delusions (1) · Dementia (1) · Hallucinations (1) · Mental Disorders (1) · Nervous System Diseases (1) · Neurocognitive Disorders (1) · Neurodegenerative Diseases (1) · Psychotic Disorders (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1) · Tauopathies (1)
Neurobehavioral Manifestations (3) · Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Nervous System Diseases (2) · Behavior (1) · Behavioral Symptoms (1)
Dexmedetomidine (2) · Saline Solution (1)
MapLight Therapeutics (1) · New Valley University (1) · Nichole Doyle (1)
United States (2) · Bulgaria (1) · Egypt (1) · France (1)
2025 (1)